Impact of physical and sexual abuse on treatment response in the treatment of resistant depression in adolescent study (TORDIA)

Wael Shamseddeen, Joan Rosenbaum Asarnow, Gregory Clarke, Benedetto Vitiello, Karen Dineen Wagner, Boris Birmaher, Martin B. Keller, Graham Emslie, Satish Iyengar, Neal D. Ryan, James T. McCracken, Giovanna Porta, Taryn Mayes, David A. Brent

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objective: We previously reported that a history of abuse was associated with a poorer response to combination treatment in the Treatment of Resistant Depression in Adolescents study (TORDIA). We now report on the nature and correlates of abuse that might explain these findings. Method: Youth who did not benefit from an adequate selective serotonin re-uptake inhibitor (SSRI) trial (N = 334) were randomized to one of the following: an alternative SSRI; an alternative SSRI plus cognitive behavior therapy (CBT); venlafaxine; or venlafaxine plus CBT. Analyses examined the effect of history of abuse on response to the pharmacotherapy and combination therapy. Results: Those without a history of physical abuse (PA) or sexual abuse (SA) had a higher 12-week response rate to combination therapy compared with medication mono-therapy (62.8% versus 37.6%; odds ratio [OR] = 2.8, 95% confidence interval [CI] = 1.6-4.7, p < .001). Those with a history of SA had similar response rates to combination versus medication monotherapy (48.3% versus 42.3%; OR = 1.3, 95% CI = 0.43.7; p = .66), whereas those with history of PA had a much lower rate of response to combination therapy (18.4% versus 52.4%, OR = 0.1; 95% CI = 0.020.43). Even after adjusting for other clinical predictors, a history of PA moderated treatment outcome. Conclusion: These results should be considered within the limitations of a post hoc analysis, lack of detailed assessment of abuse and other forms of trauma, and neuropsychological status. Depressed patients with history of abuse, especially PA may require specialized clinical approaches. Further work is needed to understand by what mechanisms a history of abuse affects treatment response. Clinical Trial Registry Information: Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); NCT00018902; http://www.clinicaltrials.gov.

Original languageEnglish (US)
Pages (from-to)293-301
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume50
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Treatment-Resistant Depressive Disorder
Sex Offenses
Serotonin Uptake Inhibitors
Odds Ratio
Cognitive Therapy
Confidence Intervals
Therapeutics
Physical Abuse
Registries
Clinical Trials
Depression
Drug Therapy
Wounds and Injuries

Keywords

  • abuse
  • cognitive behavioral therapy
  • Depression
  • selective serotonin reuptake inhibitor

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Impact of physical and sexual abuse on treatment response in the treatment of resistant depression in adolescent study (TORDIA). / Shamseddeen, Wael; Asarnow, Joan Rosenbaum; Clarke, Gregory; Vitiello, Benedetto; Wagner, Karen Dineen; Birmaher, Boris; Keller, Martin B.; Emslie, Graham; Iyengar, Satish; Ryan, Neal D.; McCracken, James T.; Porta, Giovanna; Mayes, Taryn; Brent, David A.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 50, No. 3, 03.2011, p. 293-301.

Research output: Contribution to journalArticle

Shamseddeen, W, Asarnow, JR, Clarke, G, Vitiello, B, Wagner, KD, Birmaher, B, Keller, MB, Emslie, G, Iyengar, S, Ryan, ND, McCracken, JT, Porta, G, Mayes, T & Brent, DA 2011, 'Impact of physical and sexual abuse on treatment response in the treatment of resistant depression in adolescent study (TORDIA)', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 50, no. 3, pp. 293-301. https://doi.org/10.1016/j.jaac.2010.11.019
Shamseddeen, Wael ; Asarnow, Joan Rosenbaum ; Clarke, Gregory ; Vitiello, Benedetto ; Wagner, Karen Dineen ; Birmaher, Boris ; Keller, Martin B. ; Emslie, Graham ; Iyengar, Satish ; Ryan, Neal D. ; McCracken, James T. ; Porta, Giovanna ; Mayes, Taryn ; Brent, David A. / Impact of physical and sexual abuse on treatment response in the treatment of resistant depression in adolescent study (TORDIA). In: Journal of the American Academy of Child and Adolescent Psychiatry. 2011 ; Vol. 50, No. 3. pp. 293-301.
@article{aad60b3ac6f04631bbc8f40e23f4859e,
title = "Impact of physical and sexual abuse on treatment response in the treatment of resistant depression in adolescent study (TORDIA)",
abstract = "Objective: We previously reported that a history of abuse was associated with a poorer response to combination treatment in the Treatment of Resistant Depression in Adolescents study (TORDIA). We now report on the nature and correlates of abuse that might explain these findings. Method: Youth who did not benefit from an adequate selective serotonin re-uptake inhibitor (SSRI) trial (N = 334) were randomized to one of the following: an alternative SSRI; an alternative SSRI plus cognitive behavior therapy (CBT); venlafaxine; or venlafaxine plus CBT. Analyses examined the effect of history of abuse on response to the pharmacotherapy and combination therapy. Results: Those without a history of physical abuse (PA) or sexual abuse (SA) had a higher 12-week response rate to combination therapy compared with medication mono-therapy (62.8{\%} versus 37.6{\%}; odds ratio [OR] = 2.8, 95{\%} confidence interval [CI] = 1.6-4.7, p < .001). Those with a history of SA had similar response rates to combination versus medication monotherapy (48.3{\%} versus 42.3{\%}; OR = 1.3, 95{\%} CI = 0.43.7; p = .66), whereas those with history of PA had a much lower rate of response to combination therapy (18.4{\%} versus 52.4{\%}, OR = 0.1; 95{\%} CI = 0.020.43). Even after adjusting for other clinical predictors, a history of PA moderated treatment outcome. Conclusion: These results should be considered within the limitations of a post hoc analysis, lack of detailed assessment of abuse and other forms of trauma, and neuropsychological status. Depressed patients with history of abuse, especially PA may require specialized clinical approaches. Further work is needed to understand by what mechanisms a history of abuse affects treatment response. Clinical Trial Registry Information: Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); NCT00018902; http://www.clinicaltrials.gov.",
keywords = "abuse, cognitive behavioral therapy, Depression, selective serotonin reuptake inhibitor",
author = "Wael Shamseddeen and Asarnow, {Joan Rosenbaum} and Gregory Clarke and Benedetto Vitiello and Wagner, {Karen Dineen} and Boris Birmaher and Keller, {Martin B.} and Graham Emslie and Satish Iyengar and Ryan, {Neal D.} and McCracken, {James T.} and Giovanna Porta and Taryn Mayes and Brent, {David A.}",
year = "2011",
month = "3",
doi = "10.1016/j.jaac.2010.11.019",
language = "English (US)",
volume = "50",
pages = "293--301",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Impact of physical and sexual abuse on treatment response in the treatment of resistant depression in adolescent study (TORDIA)

AU - Shamseddeen, Wael

AU - Asarnow, Joan Rosenbaum

AU - Clarke, Gregory

AU - Vitiello, Benedetto

AU - Wagner, Karen Dineen

AU - Birmaher, Boris

AU - Keller, Martin B.

AU - Emslie, Graham

AU - Iyengar, Satish

AU - Ryan, Neal D.

AU - McCracken, James T.

AU - Porta, Giovanna

AU - Mayes, Taryn

AU - Brent, David A.

PY - 2011/3

Y1 - 2011/3

N2 - Objective: We previously reported that a history of abuse was associated with a poorer response to combination treatment in the Treatment of Resistant Depression in Adolescents study (TORDIA). We now report on the nature and correlates of abuse that might explain these findings. Method: Youth who did not benefit from an adequate selective serotonin re-uptake inhibitor (SSRI) trial (N = 334) were randomized to one of the following: an alternative SSRI; an alternative SSRI plus cognitive behavior therapy (CBT); venlafaxine; or venlafaxine plus CBT. Analyses examined the effect of history of abuse on response to the pharmacotherapy and combination therapy. Results: Those without a history of physical abuse (PA) or sexual abuse (SA) had a higher 12-week response rate to combination therapy compared with medication mono-therapy (62.8% versus 37.6%; odds ratio [OR] = 2.8, 95% confidence interval [CI] = 1.6-4.7, p < .001). Those with a history of SA had similar response rates to combination versus medication monotherapy (48.3% versus 42.3%; OR = 1.3, 95% CI = 0.43.7; p = .66), whereas those with history of PA had a much lower rate of response to combination therapy (18.4% versus 52.4%, OR = 0.1; 95% CI = 0.020.43). Even after adjusting for other clinical predictors, a history of PA moderated treatment outcome. Conclusion: These results should be considered within the limitations of a post hoc analysis, lack of detailed assessment of abuse and other forms of trauma, and neuropsychological status. Depressed patients with history of abuse, especially PA may require specialized clinical approaches. Further work is needed to understand by what mechanisms a history of abuse affects treatment response. Clinical Trial Registry Information: Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); NCT00018902; http://www.clinicaltrials.gov.

AB - Objective: We previously reported that a history of abuse was associated with a poorer response to combination treatment in the Treatment of Resistant Depression in Adolescents study (TORDIA). We now report on the nature and correlates of abuse that might explain these findings. Method: Youth who did not benefit from an adequate selective serotonin re-uptake inhibitor (SSRI) trial (N = 334) were randomized to one of the following: an alternative SSRI; an alternative SSRI plus cognitive behavior therapy (CBT); venlafaxine; or venlafaxine plus CBT. Analyses examined the effect of history of abuse on response to the pharmacotherapy and combination therapy. Results: Those without a history of physical abuse (PA) or sexual abuse (SA) had a higher 12-week response rate to combination therapy compared with medication mono-therapy (62.8% versus 37.6%; odds ratio [OR] = 2.8, 95% confidence interval [CI] = 1.6-4.7, p < .001). Those with a history of SA had similar response rates to combination versus medication monotherapy (48.3% versus 42.3%; OR = 1.3, 95% CI = 0.43.7; p = .66), whereas those with history of PA had a much lower rate of response to combination therapy (18.4% versus 52.4%, OR = 0.1; 95% CI = 0.020.43). Even after adjusting for other clinical predictors, a history of PA moderated treatment outcome. Conclusion: These results should be considered within the limitations of a post hoc analysis, lack of detailed assessment of abuse and other forms of trauma, and neuropsychological status. Depressed patients with history of abuse, especially PA may require specialized clinical approaches. Further work is needed to understand by what mechanisms a history of abuse affects treatment response. Clinical Trial Registry Information: Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); NCT00018902; http://www.clinicaltrials.gov.

KW - abuse

KW - cognitive behavioral therapy

KW - Depression

KW - selective serotonin reuptake inhibitor

UR - http://www.scopus.com/inward/record.url?scp=79951856958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951856958&partnerID=8YFLogxK

U2 - 10.1016/j.jaac.2010.11.019

DO - 10.1016/j.jaac.2010.11.019

M3 - Article

VL - 50

SP - 293

EP - 301

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 3

ER -